LunarCrush LLM | creator/twitter::1404048603706970114/posts

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@AceStocks88](/creator/twitter/AceStocks88)
"$LYRA reminds me of $SNSE. Market Cap of 11.8M; 1.6M OS; 1.2ishM Float. Has Active Phase X asset that ALREADY had one successful trial. Working with FDA on new trial to address design issue. Former mover from X to around XX. Just need updates. $PRAX $MIRA $VIVK $SPRB $TTRX"  
[X Link](https://x.com/AceStocks88/status/1979168996499824827) [@AceStocks88](/creator/x/AceStocks88) 2025-10-17T12:53Z XXX followers, XX engagements


"@TT_stocks_ I like $LYRA for a watch anyway. Has an active Phase X asset and previously ran from X to XX. FDA wants one more trial but still relatively cheap here. 1.6M OS"  
[X Link](https://x.com/AceStocks88/status/1978553456521589155) [@AceStocks88](/creator/x/AceStocks88) 2025-10-15T20:07Z XXX followers, XXX engagements


"@SuperDuperInvst If $LYRA gets partnership news for financing Ph3 trial or other big news it might. 1.6M OS Biotech"  
[X Link](https://x.com/AceStocks88/status/1978554108127711611) [@AceStocks88](/creator/x/AceStocks88) 2025-10-15T20:10Z XXX followers, XXX engagements


"@Hedgenomix @stockplaymaker1 😂. I dont think there are too many retail owners but its a sleeper IMO. With low OS I think a market cap of 11M is diabolical for a co. with an asset in Phase X for something as common as sinusitis. They have to do one more trial due to a design issue but I like $LYRA here"  
[X Link](https://x.com/AceStocks88/status/1979318043353456810) [@AceStocks88](/creator/x/AceStocks88) 2025-10-17T22:46Z XXX followers, XX engagements


"@stockplaymaker1 $LYRA under the radar biotech IMO. Market Cap of 12.4M; 1.6M OS; 1.2ishM Float. Has Active Phase X asset that ALREADY had one successful trial. Working with FDA on new trial to address design issue. Former mover from X to around XX. $PRAX $MIRA $VIVK $SPRB $TTRX"  
[X Link](https://x.com/AceStocks88/status/1978867561254080637) [@AceStocks88](/creator/x/AceStocks88) 2025-10-16T16:56Z XXX followers, XXX engagements


"@UAV_Corp Wed also like to know exactly how close we are to obtaining the 50M term sheet closure & end of dilution / debt repayment. Is the weight balance analysis a condition precedent for that I sincerely hope there will be no further AS raises and no reverse split"  
[X Link](https://x.com/AceStocks88/status/1979531933911805995) [@AceStocks88](/creator/x/AceStocks88) 2025-10-18T12:56Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@AceStocks88 "$LYRA reminds me of $SNSE. Market Cap of 11.8M; 1.6M OS; 1.2ishM Float. Has Active Phase X asset that ALREADY had one successful trial. Working with FDA on new trial to address design issue. Former mover from X to around XX. Just need updates. $PRAX $MIRA $VIVK $SPRB $TTRX"
X Link @AceStocks88 2025-10-17T12:53Z XXX followers, XX engagements

"@TT_stocks_ I like $LYRA for a watch anyway. Has an active Phase X asset and previously ran from X to XX. FDA wants one more trial but still relatively cheap here. 1.6M OS"
X Link @AceStocks88 2025-10-15T20:07Z XXX followers, XXX engagements

"@SuperDuperInvst If $LYRA gets partnership news for financing Ph3 trial or other big news it might. 1.6M OS Biotech"
X Link @AceStocks88 2025-10-15T20:10Z XXX followers, XXX engagements

"@Hedgenomix @stockplaymaker1 😂. I dont think there are too many retail owners but its a sleeper IMO. With low OS I think a market cap of 11M is diabolical for a co. with an asset in Phase X for something as common as sinusitis. They have to do one more trial due to a design issue but I like $LYRA here"
X Link @AceStocks88 2025-10-17T22:46Z XXX followers, XX engagements

"@stockplaymaker1 $LYRA under the radar biotech IMO. Market Cap of 12.4M; 1.6M OS; 1.2ishM Float. Has Active Phase X asset that ALREADY had one successful trial. Working with FDA on new trial to address design issue. Former mover from X to around XX. $PRAX $MIRA $VIVK $SPRB $TTRX"
X Link @AceStocks88 2025-10-16T16:56Z XXX followers, XXX engagements

"@UAV_Corp Wed also like to know exactly how close we are to obtaining the 50M term sheet closure & end of dilution / debt repayment. Is the weight balance analysis a condition precedent for that I sincerely hope there will be no further AS raises and no reverse split"
X Link @AceStocks88 2025-10-18T12:56Z XXX followers, XXX engagements